These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 25481555)
1. Inhibitors of angiogenesis: ready for prime time? Maracle CX; Tas SW Best Pract Res Clin Rheumatol; 2014 Aug; 28(4):637-49. PubMed ID: 25481555 [TBL] [Abstract][Full Text] [Related]
2. Tripterygium wilfordii Inhibiting Angiogenesis for Rheumatoid Arthritis Treatment. Zhang W; Li F; Gao W J Natl Med Assoc; 2017 Summer; 109(2):142-148. PubMed ID: 28599756 [TBL] [Abstract][Full Text] [Related]
3. The potential role of angiogenic factors in rheumatoid arthritis. Azizi G; Boghozian R; Mirshafiey A Int J Rheum Dis; 2014 May; 17(4):369-83. PubMed ID: 24467605 [TBL] [Abstract][Full Text] [Related]
4. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models. Lee JD; Huh JE; Jeon G; Yang HR; Woo HS; Choi DY; Park DS Int Immunopharmacol; 2009 Mar; 9(3):268-76. PubMed ID: 19111632 [TBL] [Abstract][Full Text] [Related]
5. Angiogenesis as a target in rheumatoid arthritis. Koch AE Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii60-7. PubMed ID: 14532152 [No Abstract] [Full Text] [Related]
6. The vasculature in rheumatoid arthritis: cause or consequence? Paleolog EM Int J Exp Pathol; 2009 Jun; 90(3):249-61. PubMed ID: 19563609 [TBL] [Abstract][Full Text] [Related]
7. Angiogenesis as a potential treatment strategy for rheumatoid arthritis. Wang Y; Wu H; Deng R Eur J Pharmacol; 2021 Nov; 910():174500. PubMed ID: 34509462 [TBL] [Abstract][Full Text] [Related]
8. New insights in synovial angiogenesis. Szekanecz Z; Besenyei T; Paragh G; Koch AE Joint Bone Spine; 2010 Jan; 77(1):13-9. PubMed ID: 20022538 [TBL] [Abstract][Full Text] [Related]
9. Angiogenesis inhibitors for the treatment of chronic autoimmune inflammatory arthritis. Schoettler N; Brahn E Curr Opin Investig Drugs; 2009 May; 10(5):425-33. PubMed ID: 19431075 [TBL] [Abstract][Full Text] [Related]
10. Targeting of proangiogenic signalling pathways in chronic inflammation. Tas SW; Maracle CX; Balogh E; Szekanecz Z Nat Rev Rheumatol; 2016 Feb; 12(2):111-22. PubMed ID: 26633288 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-1 as regulator of angiogenesis in rheumatoid arthritis - therapeutic implications. Westra J; Molema G; Kallenberg CG Curr Med Chem; 2010; 17(3):254-63. PubMed ID: 20214567 [TBL] [Abstract][Full Text] [Related]
18. Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience. Thairu N; Kiriakidis S; Dawson P; Paleolog E Angiogenesis; 2011 Sep; 14(3):223-34. PubMed ID: 21431303 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia--a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Konisti S; Kiriakidis S; Paleolog EM Nat Rev Rheumatol; 2012 Jan; 8(3):153-62. PubMed ID: 22293762 [TBL] [Abstract][Full Text] [Related]
20. Angiogenesis as a therapeutic target in arthritis: lessons from oncology. Bainbridge J; Sivakumar B; Paleolog E Curr Pharm Des; 2006; 12(21):2631-44. PubMed ID: 16842163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]